Mos Railways Suresh Angadi succumbs to COVID-19 in AIIMS

Published: 23 September, 2020 22:10 IST | IANS | Mumbai

The 65-year-old MP from Belagavi in Karnataka was admitted in the trauma centre of AIIMS for treatment of Coronavirus disease

Minister of State for Railways Suresh Angadi with PM Narendra Modi. Pic/Twitter IANS
Minister of State for Railways Suresh Angadi with PM Narendra Modi. Pic/Twitter IANS

Minister of State for Railways Suresh Angadi succumbed to Covid-19 at New Delhi's All India Institute of Medical Sciences on Wednesday evening.

The 65-year-old MP from Belagavi in Karnataka was admitted in the trauma centre of AIIMS for treatment of Coronavirus disease and was undergoing treatment under Dr. Neeraj Nischal, associate professor in the department of medicine.

Condoling the death, Prime Minister Narendra Modi took to Twitter and wrote, "Shri Suresh Angadi was an exceptional Karyakarta, who worked hard to make the Party strong in Karnataka. He was a dedicated MP and effective Minister, admired across the spectrum. His demise is saddening. My thoughts are with his family and friends in this sad hour. Om Shanti."

Keep scrolling to read more news

Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates.

Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

Sign up for all the latest news, top galleries and trending videos from Mid-day.com

Subscribe
loading image
This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK